Jeffrey Yordon - COO, and President, Athenex Pharmaceutical Division. at Athenex, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
COO, and President, Athenex Pharmaceutical Division.
Stock Symbol
ATNXQ
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jeffrey Yordon since 9/19/2023

Holdings reported by Jeffrey Yordon for Athenex, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 246K $334K $1.36 Aug 3, 2022 Direct
Stock Option (Right to Buy) 150K Aug 3, 2022 Direct Common Stock 150K
Restricted Stock Units 37.5K Aug 3, 2022 Direct Common Stock 50K

Transactions reported by Jeffrey Yordon for Athenex, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.